ZNTL
Zentalis Pharmaceuticals, Inc.Healthcare$2.63
▲ Bullish
Mkt Cap: $186.5M|Float: 46.5M|SI: 9.0%|DTC: 5.7
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
145.3%
52W Range
$1-$4
ATR(14)
$0.22
Exp. Move
±57.0%
P/C Ratio
0.10
Earnings
May 14
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
ZNTL Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $0.5M
- Max Pain
- $2.50
- Expected Move
- ±57.0%
- Put/Call OI
- 0.10
- Net Premium
- $0.0M
- Spot Price
- $2.63
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.50 | ±57.0% | $1.13 | $4.13 |
| 2026-07-17 | 106 | ±$2.05 | ±78.0% | $0.58 | $4.68 |
| 2026-12-18 | 260 | ±$1.65 | ±62.7% | $0.98 | $4.28 |
| 2027-01-15 | 288 | ±$2.80 | ±106.5% | $-0.17 | $5.43 |
Explore ZNTL options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.